Lilly started selling Mounjaro in India in late March for diabetes and obesity, and it was so far available only in 2.5 mg ...

Around 1.5 million Brits are thought to be taking some form of weight loss drug, but there have been concerns over their link to pancreatitis and long-term side effects ...

UK mum Ellen Ogley shared her Mounjaro weight-loss journey, but had a stark warning for those who want to try it ...

India is entering a new era of medical weight loss with the introduction of powerful drugs like Wegovy, and the growing off-label use of Ozempic and ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a new study after hundreds of cases of acute and ...

Altimmune said on Thursday its experimental obesity drug met the main goal of a mid-stage trial studying it as a potential treatment for a fatty liver disease.

Eli Lilly and Novo Nordisk intensify their weight-loss drug rivalry in India as rising demand and looming generics reshape a fast-growing market.

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...

Gov. Jeff Landry struck language from the Louisiana budget plan that could have provided state employees and public school ...

UK health officials have launched a study into side-effects of weight loss drugs including Ozempic, Mounjaro and Wegovy ...

Viking Therapeutics advances its dual GLP-1/GIP obesity drug into Phase 3 trials, entering a $100 billion weight loss market. Applied Digital's $7 billion CoreWeave partnership transforms it into an ...

The total cost of funding the state's department that administers Medicaid topped $55 billion last year including federal ...